+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

North America Smart Pills Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application, Disease Indication, and End User

  • PDF Icon

    Report

  • 123 Pages
  • July 2022
  • Region: North America
  • The Insight Partners
  • ID: 5647517
UP TO OFF until Jan 15th 2023
The North America smart pills market is expected to reach US$ 5,300.85 million by 2028 from US$ 2,314.71 million in 2021. The market is estimated to grow at a CAGR of 12.6% from 2021 to 2028.

The geriatric population is highly vulnerable to gastrointestinal disorders. Various smart pills are now being analyzed for potential application in therapeutics and diagnosing several acute and chronic diseases. Patients with chronic diseases who follow a specified dose of medication at the target site are anticipated to form a large customer base for advanced drug delivery products. The increasing demand for minimally invasive surgical procedures has led to innovative techniques such as capsule endoscopy. Capsule endoscopy is expected to replace traditional endoscopy methods due to its advantages, including ease of administration and detailed observation of the gastrointestinal tract. The capsule endoscopy plays a vital role in the early diagnosis and proper treatment of these disorders, along with hybrid imaging technologies and new component innovations. For instance, as per the University of Texas Health Science Center, the deployment of various colorectal cancer screening procedures, such as capsule endoscopy, improves adherence to screening. The university conducted a study comprising randomly assigned patients aged 50 to 75 and inferred that capsule endoscopy gives better diagnostic results than CT colonography. Such findings are estimated to boost the segment growth over the forecast period. Patients with a maximal requirement for home healthcare services face challenges concerning access and use of smart pills. This has resulted in developers and producers increasing the accessibility and usability of these devices, thereby facilitating the interpretation of data more simply. Most industries offer compatible software for collecting data over a longer duration, conveying valuable information about patient health, and providing suggestions for enhancing their quality of life. Being connected to smartphones through Bluetooth and providing data in user-friendly & statistical format is boosting the demand for smart pills.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the smart pills market. The North America smart pills market is expected to grow at a good CAGR during the forecast period.

North America Smart Pills Market Segmentation

The North America smart pills market is segmented based on application, disease indication, and end user. Based on application, the market is segmented into capsule endoscopy, drug delivery, and patient monitoring. The capsule endoscopy segment is sub segmented into small bowel video capsule endoscopy, colon capsule endoscopy, controllable capsule endoscopy, storable capsule endoscopy, and other capsule endoscopy. Based on disease indication, the market is segmented into gastrointestinal diseases, neurological disorders, cancer, inherited disorders, and other disease indications. Based on end user, the market is segmented into hospitals and clinics, research institutes, and home healthcare. By Country, the North America smart pills market is segmented into the US, Mexico, and Canada.

Companies Mentioned

Capso Vision, Inc.; Medtronic; Check-Cap; PENTAX Medical; Olympus Corporation; and Otsuka Holdings Co., Ltd are among the leading companies in the North America smart pills market.
Frequently Asked Questions about the North American Smart Pills Market

What is the estimated value of the North American Smart Pills Market?

The North American Smart Pills Market was estimated to be valued at $2314.71 Million in 2022.

What is the growth rate of the North American Smart Pills Market?

The growth rate of the North American Smart Pills Market is 12.6%, with an estimated value of $5300.85 Million by 2028.

What is the forecasted size of the North American Smart Pills Market?

The North American Smart Pills Market is estimated to be worth $5300.85 Million by 2028.

Who are the key companies in the North American Smart Pills Market?

Key companies in the North American Smart Pills Market include Capso Vision, Inc., Medtronic, Check, Cap, PENTAX Medical and Otsuka Holdings Co., Ltd..

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Smart Pills Market - By Application
1.3.2 North America Smart Pills Market - By Disease Indication
1.3.3 North America Smart Pills Market - By End User
1.3.4 North America Smart Pills Market - By Country
2. North America Smart Pills Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Smart Pills Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.3 Expert Opinion
5. North America Smart Pills Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Demand for Minimally Invasive Surgical Procedures
5.1.2 Increase in Strategic Collaborations & Partnerships On Smart Pills
5.2 Market Restraints
5.2.1 High Cost of Smart Pill
5.3 Market Opportunities
5.3.1 Increasing Demand for Drug Delivery System
5.4 Future Trends
5.4.1 Remote Patient Monitoring Through Smart Pills
6. North America Smart Pills Market -Country Analysis
6.1 North America Smart Pills Market Revenue Forecast and Analysis
6.1.1 North America Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
7. North America Smart Pills Market Analysis - By Application
7.1 Overview
7.2 North America Smart Pills Market, By Application, 2021 & 2028 (%)
7.2.1 North America North America Smart Pills Market, by Application- Revenue and Forecast to 2028 (USD Million)
7.2.1.1 North America North America Smart Pills Market, by Capsule Endoscopy - Revenue and Forecast to 2028 (USD Million)
7.3 Capsule Endoscopy
7.3.1 Overview
7.3.2 Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
7.3.3 Small Bowel Video Capsule Endoscopy
7.3.3.1 Overview
7.3.3.2 Small Bowel Video Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
7.3.4 Colon Capsule Endoscopy
7.3.4.1 Overview
7.3.4.2 Colon Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
7.3.5 Controllable Capsule Endoscopy
7.3.5.1 Overview
7.3.5.2 Controllable Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
7.3.6 Storable Capsule Endoscopy
7.3.6.1 Overview
7.3.6.2 Storable Capsule Endoscope: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
7.3.7 Other Capsule Endoscopy
7.3.7.1 Overview
7.3.7.2 Other Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Drug Delivery
7.4.1 Overview
7.4.2 Drug Delivery: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Patient Monitoring
7.5.1 Overview
7.5.2 Patient Monitoring: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
8. North America Smart Pills Market Revenue and Forecasts To 2028 - Disease Indication
8.1 Overview
8.2 North America Smart Pills Market Share by Disease Indication - 2021 & 2028 (%)
8.2.1 North America North America Smart Pills Market, by Disease Indication - Revenue and Forecast to 2028 (USD Million)
8.3 Gastrointestinal Diseases
8.3.1 Overview
8.3.2 Gastrointestinal Diseases: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
8.4 Neurological Disorders
8.4.1 Overview
8.4.2 Neurological Disorders: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
8.5 Cancer
8.5.1 Overview
8.5.2 Cancer: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
8.6 Inherited Disorders
8.6.1 Overview
8.6.2 Inherited Disorders: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
8.7 Other Disease Indications
8.7.1 Overview
8.7.2 Other Disease Indications: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
9. North America Smart Pills Market Revenue and Forecasts To 2028 - End User
9.1 Overview
9.2 North America Smart Pills Market Share by End User - 2021 & 2028 (%)
9.2.1 North America North America Smart Pills Market, by End User - Revenue and Forecast to 2028 (USD Million)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
9.4 Research Institutes
9.4.1 Overview
9.4.2 Research Institutes: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
9.5 Home Healthcare
9.5.1 Overview
9.5.2 Home Healthcare: North America Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
10. North America Smart Pills Market - Regional Analysis
10.1 North America: North America Smart Pills Market
10.1.1 Overview
10.1.2 North America: North America Smart Pills Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: North America Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: North America Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 US North America Smart Pills Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3.1 US North America Smart Pills Market, by Capsule Endoscopy - Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 US North America Smart Pills Market, by Disease Indication - Revenue and Forecast to 2028 (USD Million)
10.1.2.1.5 US North America Smart Pills Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Canada: North America Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: North America Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Canada North America Smart Pills Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3.1 Canada North America Smart Pills Market, by Capsule Endoscopy - Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 Canada North America Smart Pills Market, by Disease Indication - Revenue and Forecast to 2028 (USD Million)
10.1.2.2.5 Canada North America Smart Pills Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.2.3 Mexico: North America Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico: North America Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 Mexico North America Smart Pills Market, by Application- Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3.1 Mexico North America Smart Pills Market, by Capsule Endoscopy - Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 Mexico North America Smart Pills Market, by Disease Indication - Revenue and Forecast to 2028 (USD Million)
10.1.2.3.5 Mexico North America Smart Pills Market, by End User - Revenue and Forecast to 2028 (USD Million)
11. North America Smart Pills Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the North America Smart Pills Market, 2021-2028
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 CapsoVision, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Check-Cap
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 PENTAX Medical
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Olympus Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Otsuka Holdings Co., Ltd.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
List of Figures
Figure 1. North America Smart Pills Market Segmentation
Figure 2. North America Smart Pills Market Overview
Figure 3. Capsule Endoscopy Segment Held Largest Share by Application in North America Smart Pills Market
Figure 4. US Is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America: PEST Analysis
Figure 6. North America Smart Pill Market Impact Analysis of Drivers and Restraints
Figure 7. North America Smart Pills Market - Revenue Forecast and Analysis - 2021- 2028
Figure 8. North America Smart Pills Market, by Application, 2021 & 2028 (%)
Figure 9. Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 10. Small Bowel Video Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 11. Colon Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Controllable Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Storable Capsule Endoscope: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Other Capsule Endoscopy: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Drug Delivery: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Patient Monitoring: North America Smart Pills Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. North America Smart Pills Market Share by Disease Indication - 2021 & 2028 (%)
Figure 18. Gastrointestinal Diseases: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. Neurological Disorders: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20. Cancer: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. Inherited Disorders: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. Other Disease Indications: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. North America Smart Pills Market Share by End User - 2021 & 2028 (%)
Figure 24. Hospitals and Clinics: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Research Institutes: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Home Healthcare: North America Smart Pills Market Revenue and Forecasts To 2028 (US$ Million)
Figure 27. North America: North America Smart Pills Market, by Key Country - Revenue (2021) (USD Million)
Figure 28. North America: North America Smart Pills Market, by Country, 2021 & 2028 (%)
Figure 29. US: North America Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
Figure 30. Canada: North America Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
Figure 31. Mexico: North America Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
Figure 32. Growth Strategies in the North America Smart Pills Market, 2021-2028
List of Tables
Table 1. North America Smart Pills Market - Revenue and Forecast to 2028 (USD Million)
Table 2. North America North America Smart Pills Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 3. North America North America Smart Pills Market, by Capsule Endoscopy - Revenue and Forecast to 2028 (USD Million)
Table 4. North America North America Smart Pills Market, by Disease Indication - Revenue and Forecast to 2028 (USD Million)
Table 5. North America North America Smart Pills Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 6. US North America Smart Pills Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 7. US North America Smart Pills Market, by Capsule Endoscopy - Revenue and Forecast to 2028 (USD Million)
Table 8. US North America Smart Pills Market, by Disease Indication - Revenue and Forecast to 2028 (USD Million)
Table 9. US North America Smart Pills Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 10. Canada North America Smart Pills Market, by Application-Revenue and Forecast to 2028 (USD Million)
Table 11. Canada North America Smart Pills Market, by Capsule Endoscopy -Revenue and Forecast to 2028 (USD Million)
Table 12. Canada North America Smart Pills Market, by Disease Indication -Revenue and Forecast to 2028 (USD Million)
Table 13. Canada North America Smart Pills Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico North America Smart Pills Market, by Application -Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico North America Smart Pills Market, by Capsule Endoscopy -Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico North America Smart Pills Market, by Disease Indication -Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico North America Smart Pills Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 18. Recent Inorganic Growth Strategies in the North America Smart Pills Market
Table 19. Recent Organic Growth Strategies in the North America Smart Pills Market
Table 20. Glossary of Terms, North America Smart Pills Market

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Capso Vision, Inc.
  • Medtronic
  • Check-Cap
  • PENTAX Medical
  • Olympus Corporation
  • Otsuka Holdings Co., Ltd.